Abstract: The invention relates to a composition of glycosaminoglycans for the treatment of diabetic foot ulcer, it specifically relates to low molecular weight heparins (LMWHs) and very low molecular weight heparins (VLMWHs) in the treatment of chronic ulcers, particularly of diabetic foot ulcers, and more specifically in the manufacture of a medicinal product for the treatment of chronic ulcers, and particularly diabetic foot ulcers and pressure ulcers.
Type:
Grant
Filed:
September 5, 2013
Date of Patent:
December 15, 2015
Assignee:
Laboratories Farmaceuticos Roui, S.A.
Inventors:
Ivan Lopez-Belmonte Encina, Maria De Los Angeles Canales Mayordomo, Elena Cebadera Miranda